SIMX, INC

Seed / Series A

defense-other · Seed

Seed Signal Score

14/25

Team Strength

2/5

Validation Depth

3/5

Novelty

3/5

Market Timing

3/5

Capital Efficiency

3/5

Funding

$1.8M

Total raised

$1.8M

Last round · May 17, 2023

Description

TACFI: End-User Scenario Authoring and Configuration for VR Medical Simulation Training

Validation Signals

SBIR Phase II

Score Rationale

SIMX has secured SBIR Phase I and Phase II awards, providing validation depth in a government-contracted space, but team details are entirely absent—no founder names, backgrounds, or credentials are provided, making team assessment speculative. The VR medical simulation training space is moderately crowded (existing players like CAE, Immersive Labs) and while scenario authoring tools address a real DoD medical readiness need, the differentiation is unclear and market pull signals beyond SBIR are not evident.

Back to all companies